SUBSCRIBE
SUBSCRIBE

Salarius Pharmaceuticals

NEWS
Drug Development
Salarius Stock Plunges 27% After Death in Sarcoma Trial
Salarius Pharmaceuticals voluntarily paused enrollment of its Phase I/II trial of seclidemstat for Ewing sarcoma and FET-rearranged sarcomas after a patient’s death.
October 18, 2022
 · 
2 min read
 · 
Mark Terry
Biotech Beach
BIO Returns to San Diego with Innovation and Partnering on the Menu
The annual BIO convention has returned, bringing thousands of life sciences companies worldwide to the annual networking event that could spark collaborations and deals.
June 14, 2022
 · 
3 min read
 · 
Alex Keown
IN THE PRESS
Lone Star Bio
Salarius Pharmaceuticals to Present SP-3164 at the 5th Annual Targeted Protein Degradation Conference
October 19, 2022
 · 
5 min read
Drug Development
Salarius Pharmaceuticals Announces Pause in New Patient Enrollment in its Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma and FET-Rearranged Sarcomas
October 18, 2022
 · 
7 min read
Lone Star Bio
Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split
October 14, 2022
 · 
3 min read
Lone Star Bio
Salarius Pharmaceuticals to Present at the 2022 Ladenburg Thalmann Healthcare Conference
September 20, 2022
 · 
1 min read
Lone Star Bio
Salarius Pharmaceuticals CEO Issues Letter to Stockholders - September 13, 2022
September 13, 2022
 · 
11 min read
Drug Development
Salarius Pharmaceuticals Adds Two Mayo Clinic Sites to its Ongoing Phase 1/2 Trial of Seclidemstat as a Treatment for Ewing’s Sarcoma and FET-Rearranged Sarcomas
August 22, 2022
 · 
7 min read
Business
Salarius Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
August 8, 2022
 · 
10 min read
Drug Development
Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat
August 4, 2022
 · 
7 min read
Business
Salarius Pharmaceuticals and VolitionRx Enter into R&D Collaboration Agreement
August 2, 2022
 · 
6 min read
Business
Salarius Pharmaceuticals to Host Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 8, 2022
July 29, 2022
 · 
5 min read
Load More
JOBS